Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.980
-0.150 (-4.79%)
Feb 21, 2025, 4:00 PM EST - Market closed
Skye Bioscience Employees
Skye Bioscience had 11 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,930,961
Market Cap
90.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
SKYE News
- 2 days ago - Skye Bioscience to Present at TD Cowen Health Care Conference - GlobeNewsWire
- 18 days ago - Skye Bioscience Announces Participation in February Conferences - GlobeNewsWire
- 19 days ago - MoneyShow's Best Investment Ideas For 2025: Part 8 - Seeking Alpha
- 2 months ago - Skye Bioscience to Present at J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Skye Bioscience: Nimacimab Targets Safer Weight Loss, Speculative Buy - Seeking Alpha
- 3 months ago - Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor - GlobeNewsWire
- 3 months ago - Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire